Skip to main content
University of California San Francisco
UCSF Health
Search UCSF
About UCSF
Search form
Search...
Twitter
About
Outreach
Vision
Neuroscience Program Bylaws
DEI
Support for Students with Disabilities
Admissions
Application Process
Other Considerations
Frequently Asked Questions
Graduate Student Fair
Current Students
Student Handbook
1st Year Student Companion Guide
2nd Year Student Companion Guide
3rd Year+ Student Companion Guide
Quals Handbook Companion Guide_2021
Forms
Additional Resources
Curriculum
Course List
UCSF Course Catalog
Study List Filing Info
UCSF Academic Calendar
Faculty
Events
Annual Retreat
Formal Seminar Series
External Postdoc Seminar Program (EPSP)
Neuroscience Program and Community Calendar
RIPS
Kavli Faculty Seminar
Contact
You are here
Home
>
Blood
Blood
Next-Generation NAMPT Inhibitors For ALL Identified By Sequential High-Throughput Phenotypic Chemical and Functional Genomic Screens.
Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach.
Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach.
PI-103, a Dual Inhibitor of Class I Phosphatidylinositide 3-Kinase and mTOR, Has Anti-Leukemic Activity in Acute Myeloid Leukemia.
Importance of PI3 Kinase Family for Crosstalk between Chronic Lymphocytic Leukemia B Cells and the Stromal Microenvironment: Therapeutic Implications.
Knock-outs and inhibitors: one and the same?.
Another possible mechanism of resistance to STI571.
Another possible mechanism of resistance to STI571.
Another possible mechanism of resistance to STI571.
A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells.
Pages
« first
‹ previous
1
2
3
next ›
last »